Opioids With Abuse-Deterrent Labeling

Only two of the six ER/LA opioids approved with abuse-deterrent labeling target the oral route of abuse.

FDA has approved six extended-release/long-acting opioid analgesic products with labeling that describes studies conducted to support abuse-deterrent properties.

There are no immediate-release single-entity or combination opioid products labeled with abuse-deterrent claims pursuant to the agency's April 2015 final...

More from United States

More from North America